Robert Meier, M.D. - complete profile

Radiation Oncologist
Medical Director, Swedish Cancer Institute at Northwest Hospital

Return to top of page  |  Education & Certification  |  Clinical Interests  |  Professional Highlights  |  Research & Selected Publications  |  Selected Presentations  

Education & Certification

Medical School: UCLA David Geffen School of Medicine, Los Angeles, Calif.

Internship: St. Mary Medical Center, Long Beach, Calif.

Residency: UCLA David Geffen School of Medicine, Los Angeles, Calif. (Radiation Oncology)

Board Certification: Board certified in therapeutic radiology (American Board of Radiology)

Additional Certifications: CyberKnife (Accuray)

Return to top of page  |  Education & Certification  |  Clinical Interests  |  Professional Highlights  |  Research & Selected Publications  |  Selected Presentations  

Clinical Interests

• CyberKnife treatment for cancerous and noncancerous tumors anywhere in the body, including:

	• Brain • Lung	• Breast • Pancreas	• Head & Neck • Pelvis	• Kidney • Prostate	• Liver • Spine
	See All Conditions Treated

• Oncology

Return to top of page  |  Education & Certification  |  Clinical Interests  |  Professional Highlights  |  Research & Selected Publications  |  Selected Presentations  

Professional Highlights

• Prospective Evaluation of CyberKnife Radiosurgery of Low and Intermediate Risk Prostate Cancer+ Homogeneous Does Distribution, Swedish Cancer Institute. (principal investigator)
• Medical Director, Swedish Cancer Institute at Northwest Hospital, Seattle, Wash. (1998 - present)
• Adjunct Clinical Assistant Professor of Radiation Oncology, Stanford University School of Medicine, Palo Alto, Calif. (1990 - 2005)
• CyberKnife Society, Protocol Development Committee (member)
• Member of the American Society for Therapeutic Radiology and Oncology and the Northern California Radiation Oncology Society

Return to top of page  |  Education & Certification  |  Clinical Interests  |  Professional Highlights  |  Research & Selected Publications  |  Selected Presentations  

Research & Selected Publications

Research & Clinical Trials

• Prospective Evaluation of CyberKnife Radiosurgery of Low and Intermediate Risk Prostate Cancer+ Homogeneous Does Distribution, Swedish Cancer Institute. (principal investigator)

Selected Publications

”Radiosurgery for Organ-Confined Prostate Cancer: Early Toxicity Outcomes from a Multi-institutional Trial ”, accepted for
         poster presentation, the American Urologic Association meeting,
          June 2010.

Meier, R., ”Robotic Radiosurgery for Organ-Confined Prostate Cancer: Early Toxicity Outcomes from a Multi-institutional Trial,” Journal of Urology, Vol. 183(4S), 2010, p.185.

Meier, R., and C. Cotrutz, ”MRI-planned Stereotactic Body Radiotherapy for Organ-confined Prostate Cancer: Feasibility & Early Results,” International Journal of Radiation Oncology, Biology, Physics, Vol. 75, No. 3, 2009, S334.

Meier, R., and V.K. Mehta, S. Vermeulen, R. Young, ”Dose-Response and Dose-Complication Relationships in Stereotactic Radiosurgery for Trigeminal Neuralgia,” International Journal of Radiation Oncology, Biololgy, Physics, Vol. 60, No. 1, 2004, p. S547, 2004. (abstract)

Meier, R., and J. Hatton, V.K. Mehta, ”Forward-Planning Breast IMRT: Early Clinical Experience,” International Journal of Radiation Oncology, Biology, Physics, Vol. 57, No. 2, 2003, p. S368. (abstract)

Meier, R., and M. Brawer, ”Selecting Treatment for High-Risk, Localized Prostate Cancer: The Case for Radiation Therapy,” Reviews in Urology, Vol. 4, No. 3, 2002, pp. 141-46.

Meier, R., and P. Balousek, ”Radiation Therapy for Brain Metastases,” Northwest Neuroscience Institute Journal, Vol. 6, 1999, pp. 2-3.

Meier, R., and R. Mark, L. St. Royal, L. Tran, G. Colburn, R. Parker, ”Postoperative Radiotherapy Following Radical Prostatectomy for Prostate Carcinoma,” Cancer, Vol. 70, 1992, pp. 1960-1966.

Sylvester, J., and J. Blasko, P. Grimm, R. Meier, J. Malmgren, ”Ten-Year Biochemical Relapse-Free Survival After ExternalBeam Radiation and Brachytherapy for Localized Prostate Cancer: The Seattle Experience,” International Journal of Radiation Oncology, Biology, Physics, Vol. 57, No. 4, 2003, pp. 944-52.

Grimm, P., and J. Blasko, J. Sylvester, R. Meier, W. Cavanagh. ”Ten-Year Biochemical (Prostate- Specific Antigen) Control of Prostate Cancer with 125-I Brachytherapy,” International Journal of Radiation Oncology, Biology, Physics, Vol. 51, No. 1, 2001, pp. 31-40.

Sylvester, J., and P. Grimm, J. Blasko, R. Meier, J. Spiegel, C. Heaney, W. Cavanagh, ”The Role of Androgen Ablation in Patients with Biochemical or Local Failure after Definitive Radiation Therapy: A Survey of Practice Patterns or Urologists and Radiation Oncologists in the United States,” Urology, Vol. 58 (2 suppl 1), 2001, pp. 65-70.

Grimm, P., and J. Blasko, J. Sylvester, W. Cavanagh, R. Meier, ”Ten Year Biochemical Outcomes Following 125-Iodine Monotherapy for Early Stage Prostate Cancer,” International Journal of Radiation Oncology, Biology, Physics, Vol. 48, No. 3, 2000, pp. 146-147.

Sylvester, J., and J. Blasko, P. Grimm, R. Meier, W. Cavanagh. ”Short-Course Androgen Ablation Combined with External-Beam Radiation Therapy and Low-Dose-Rate Brachytherapy in Early-Stage Prostate Cancer: A Matched Subset Analysis,” Molecular Urology, Vol. 4, No. 3, 2000, pp. 155-59.

Vermeulen, S., and R. Young, F. Li, R. Meier, J. Raisis, S. Klein, E. Kohler, ”Comparison of Single Fraction Radiosurgery Tumor Control and Toxicity in the Treatment of Basal and Nonbasal Meningiomas,” Stereotactic & Functional Neurosurgery, Vol. 72(suppl. 1), 1999, pp. 60-66.

Sylvester, J., and J. Blasko, P. Grimm, R. Meier, G. Colburn, B. Goy, W. Cavanagh, ”Neoadjuvant Androgen Ablation Combined with Exernal Beam Radiotherapy and Brachytherapy in Early Stage Prostate Cancer,” Molecular Urology, Vol. 3, 1999, pp. 231-238.

Return to top of page  |  Education & Certification  |  Clinical Interests  |  Professional Highlights  |  Research & Selected Publications  |  Selected Presentations  

Selected Presentations

”MRI-planned stereotactic body radiotherapy for organ-confined prostate cancer: feasibility and early results”, accepted for
         presentation, American Society for Therapeutic Radiology and
         Oncology (ASTRO) meeting, November 2009.

”Stereotactic Body Radiotherapy for Organ-Confined Prostate Cancer: Feasibility and Early Results,” 91st Annual Meeting of the
         American Radium Society, April 2009.

”The Seattle Cyberknife Start-up Experience,” Cyberknife Users' Meeting, Chicago, Ill., April 2006.

”Dose-Response and Dose-Complication Relationships in Stereotactic Radiosurgery for Trigeminal Neuralgia,” American Society for Therapeutic Radiation Oncology, Atlanta, Ga., October 2004.

”Forward-Planning Breast IMRT: Early Clinical Experience,” American Society for Therapeutic Radiation Oncology, Salt Lake City, Utah, October 2003.

”Acute Genitourinary Complications of Permanent Interstitial Prostate Brachytherapy,” Radiologic Society of North America, November 1999.

”Postoperative Radiation Therapy for Pathologic Stage C Prostate Carcinoma,” American Radium Society, April 1989.

Return to top of page  |  Education & Certification  |  Clinical Interests  |  Professional Highlights  |  Research & Selected Publications  |  Selected Presentations